細胞療法追蹤市場規模、佔有率和成長分析：按組件、部署、應用、最終用戶、療法類型和地區分類 - 行業預測，2026-2033 年

2024 年全球細胞治療追蹤市場價值為 48.6 億美元，預計到 2025 年將成長至 53.2 億美元，到 2033 年將成長至 109.1 億美元，在預測期（2026-2033 年）內複合年成長率為 9.4%。

市場分析表明，監管合規是細胞治療行業成長的主要驅動力。世界各國政府都在優先考慮細胞產品的透明度和標準合規性，這迫使製造商實施強大的追蹤解決方案，將生產數據與臨床結果關聯起來。這種整合正在推動流程控制的改進，並增加對能夠整合感測器數據、條碼掃描和患者追蹤記錄的雲端分析平台的需求。因此，醫療機構可以證明產品的一致性，並簡化保險報銷流程。利用這些先進追蹤系統的醫院可以獲得許多益處，例如減少產品損耗、縮短運輸週期以及為與支付方談判提供更有力的證據，最終為細胞治療市場的供應商創造新的商機。

全球細胞療法追蹤市場促進因素

細胞生產技術的持續進步顯著提高了產品質量，最大限度地降低了污染風險，並縮短了生產時間。所有這些都增強了臨床可靠性，並改善了患者的治療效果。自動化生物反應器和封閉式系統製程的引入，使製造商能夠在保持嚴格品質標準的同時，有效地擴大生產規模。這項創新增強了醫療專業人員和投資者的信心，促進了細胞療法的廣泛應用，並透過拓展治療選擇和最佳化供應鏈推動了市場成長。此外，標準化細胞劑量的生產能力有助於進行多中心臨床試驗，並簡化法規核准流程，進一步提升了市場活力。

全球細胞療法追蹤市場的限制因素

全球細胞療法追蹤市場面臨嚴峻挑戰，主要原因是細胞療法的高昂成本限制了許多患者的治療機會，並給醫療預算帶來了巨大壓力。生產流程的複雜性、個人化生產的需求以及嚴格的品管措施都推高了成本，導致保險公司往往不願意全額報銷。因此，醫療專業人員可能會選擇更經濟實惠的治療方案，這可能導致細胞療法的普及率下降。此外，高成本也阻礙了一些醫療機構建立專門的治療設施，而缺乏健全的報銷機制也限制了市場的成長潛力。

全球細胞療法追蹤市場趨勢

全球細胞治療追蹤市場正經歷一場變革，其驅動力來自技術和製造流程的進步。個人化細胞生產的興起，得益於基因編輯和封閉式生物反應器等創新技術，使得大規模生產針對特定病患的細胞產品成為可能。製造商正從集中式生產設施轉向分散式即時治療中心，從而最大限度地縮短運輸時間，保持細胞活性，加強品管，並加速臨床療效。這種在地化生產策略正在推動對模組化單元和客製化供應鏈的投資增加，進一步加速了其在包括腫瘤學和再生醫學在內的各個治療領域的廣泛應用，最終改善全球患者的治療效果。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球細胞療法追蹤市場規模：按成分分類

• 軟體
• 服務

全球細胞療法追蹤市場規模：按部署類型分類

• 基於雲端的
• 現場

全球細胞療法追蹤市場規模：按應用分類

• 身份鏈 (COI)
• 監管鏈 (CoC)
• 生產追蹤
• 物流追蹤

全球細胞療法追蹤市場規模：按最終用戶分類

• 細胞療法生產商
• 醫院
• 合約研發生產組織（CDMO）

全球細胞療法追蹤市場規模：按療法類型分類

• CAR-T細胞療法
• 幹細胞療法
• 基因修飾細胞療法

全球細胞療法追蹤市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Veeva Systems Inc.
• TrakCel Ltd.
• Azenta Life Sciences
• Lonza Group AG
• Bio-Techne Corporation
• Thermo Fisher Scientific Inc.
• Oracle Corporation
• SAP SE
• Vineti, Inc.
• Be The Match BioTherapies
• Cryoport Systems, LLC
• MasterControl Solutions, Inc.
• TraceLink Inc.
• LabVantage Solutions, Inc.
• Calyx
• BioIVT
• CellPoint Digital
• Cytiva
• StemCell Technologies Inc.
• IQVIA Holdings Inc.

結論與建議

Global Cellular Therapy Tracking Market size was valued at USD 4.86 Billion in 2024 and is poised to grow from USD 5.32 Billion in 2025 to USD 10.91 Billion by 2033, growing at a CAGR of 9.4% during the forecast period (2026-2033).

Market insights indicate that regulatory compliance is a key driver of growth in the cellular therapy sector. Governments are emphasizing transparency and adherence to cell-product standards, prompting manufacturers to adopt robust tracking solutions that align manufacturing data with clinical outcomes. This integration fosters improved process control and escalates the demand for cloud-based analytics platforms capable of consolidating sensor data, barcode scans, and patient follow-up records. As a result, healthcare providers can demonstrate product consistency and facilitate reimbursement processes. Hospitals utilizing these advanced tracking systems benefit from reduced product loss, expedited release cycles, and enhanced evidence for payer negotiations, ultimately creating new revenue opportunities for vendors in the cellular therapy market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cellular Therapy Tracking market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cellular Therapy Tracking Market Segments Analysis

Global cellular therapy tracking market is segmented by component, deployment, application, end user, therapy type and region. Based on component, the market is segmented into Software and Services. Based on deployment, the market is segmented into Cloud-Based and On-Premises. Based on application, the market is segmented into Chain of Identity, Chain of Custody, Manufacturing Tracking and Logistics Tracking. Based on end user, the market is segmented into Cell Therapy Manufacturers, Hospitals and Contract Development & Manufacturing Organizations. Based on therapy type, the market is segmented into CAR-T Cell Therapy, Stem Cell Therapy and Gene-Modified Cell Therapy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cellular Therapy Tracking Market

The continuous advancement in cell manufacturing methods significantly boosts product quality, minimizes contamination risks, and expedites production times, all of which enhance clinical reliability and improve patient outcomes. Through the incorporation of automated bioreactors and closed-system processes, manufacturers can efficiently scale their operations while upholding strict quality standards. This innovation fosters greater confidence among healthcare providers and investors, promoting the broader acceptance of cellular therapies and driving market growth through enhanced therapeutic options and optimized supply chains. Additionally, the capability to create standardized cell doses facilitates multi-center trials, streamlining regulatory approval processes and further energizing market dynamics.

Restraints in the Global Cellular Therapy Tracking Market

The Global Cellular Therapy Tracking market faces considerable challenges due to the high financial burden linked with cellular therapies, which restricts access for many patients and places significant pressure on healthcare budgets. The intricacies involved in production, the need for personalized manufacturing, and stringent quality control measures contribute to elevated costs that insurance providers often hesitate to fully cover. As a result, healthcare professionals may opt for more affordable treatment alternatives, leading to a decline in the adoption of cellular therapies. Additionally, the high costs deter some providers from creating specialized treatment facilities, hindering the market's growth potential in the absence of robust reimbursement mechanisms.

Market Trends of the Global Cellular Therapy Tracking Market

The Global Cellular Therapy Tracking market is experiencing a transformative shift driven by advancements in technology and manufacturing processes. The rise of personalized cell manufacturing is enabling the production of patient-specific cellular products at scale, facilitated by innovations such as gene editing and closed-system bioreactors. Manufacturers are transitioning from centralized facilities to decentralized, point-of-care hubs, which not only minimize transit times and preserve cell potency but also enhance quality control and expedite clinical responses. This localized production strategy is spurring increased investments in modular units and customized supply chains, further promoting broader adoption across various therapeutic areas, including oncology and regenerative medicine, thereby improving patient outcomes globally.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Cellular Therapy Tracking Market Size by Component & CAGR (2026-2033)

• Market Overview
• Software
• Services

Global Cellular Therapy Tracking Market Size by Deployment & CAGR (2026-2033)

• Market Overview
• Cloud-Based
• On-Premises

Global Cellular Therapy Tracking Market Size by Application & CAGR (2026-2033)

• Market Overview
• Chain of Identity
• Chain of Custody
• Manufacturing Tracking
• Logistics Tracking

Global Cellular Therapy Tracking Market Size by End User & CAGR (2026-2033)

• Market Overview
• Cell Therapy Manufacturers
• Hospitals
• Contract Development & Manufacturing Organizations

Global Cellular Therapy Tracking Market Size by Therapy Type & CAGR (2026-2033)

• Market Overview
• CAR-T Cell Therapy
• Stem Cell Therapy
• Gene-Modified Cell Therapy

Global Cellular Therapy Tracking Market Size & CAGR (2026-2033)

• North America (Component, Deployment, Application, End User, Therapy Type)
  • US
  • Canada
• Europe (Component, Deployment, Application, End User, Therapy Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Deployment, Application, End User, Therapy Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Deployment, Application, End User, Therapy Type)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Deployment, Application, End User, Therapy Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Veeva Systems Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TrakCel Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azenta Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAP SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vineti, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Be The Match BioTherapies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryoport Systems, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MasterControl Solutions, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TraceLink Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabVantage Solutions, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Calyx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioIVT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CellPoint Digital
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytiva
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StemCell Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations